仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Pidilizumab （CT-011） is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research